Jody Voorspoels

Biography

  Jody Voorspoels joined SEPS Pharma as Chief Scientific Officer and Head of the Pharmaceutical Development Division in July 2009 from Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) where he was responsible for the development of solid dosage forms. He has a broad experience in the formulation and process development of anti-infective, CNS, metabolic and oncology drugs and developed immediate and controlled release systems for water soluble to poorly soluble drugs. He obtained two Johnson & Johnson awards for his work on the formulation and spray drying technology for Intelence®, a novel NNRTI HIV drug. He started his professional career at Tibotec (a subsidiary of Johnson & Johnson) in 2000. Jody holds a Master’s degree in Pharmaceutical Sciences from Ghent University in Belgium where he also obtained his PhD focusing on pharmaceutical technology. In 2015 SEPS Pharma was acquired by Amatsigroup and changed its name to AmatsiSEPS.

Research Interest

 Drug development